• Repurposing rheumatology drugs for COVID-19: Hydroxychloroquine (with Alfred Kim)

  • Jan 11 2021
  • Duración: 17 m
  • Podcast

Repurposing rheumatology drugs for COVID-19: Hydroxychloroquine (with Alfred Kim)  Por  arte de portada

Repurposing rheumatology drugs for COVID-19: Hydroxychloroquine (with Alfred Kim)

  • Resumen

  • In this series of podcasts we are speaking to the experts about repurposing rheumatology drugs for the treatment and prevention of COVID-19.

    In this episode, Alfred (Al) Kim, a rheumatologist from the Washington University School of Medicine in St Louis, Missouri, USA, talks about hydroxychloroquine. He discusses why the drug was initially considered promising but later shown to be ineffective, and describes the impact drug shortages have had on rheumatology practice.

    Find more on Medicine Matters rheumatology

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Repurposing rheumatology drugs for COVID-19: Hydroxychloroquine (with Alfred Kim)

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.